Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.70 |
| ▸ | MAPT | P10636 | 6/20 | 0.70 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.70 |
| ▸ | MEN1 | O00255 | 4/20 | 0.70 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.70 |
| ▸ | GAA | P10253 | 2/20 | 0.70 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.70 |
| ▸ | THRB | P10828 | 1/20 | 0.70 |
| ▸ | LMNA | P02545 | 4/20 | 0.60 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.60 |
| ▸ | CA12 | O43570 | 2/20 | 0.55 |
| ▸ | CA1 | P00915 | 2/20 | 0.55 |
| ▸ | CA2 | P00918 | 2/20 | 0.55 |
| ▸ | CA9 | Q16790 | 2/20 | 0.55 |
| ▸ | MAOB | P27338 | 1/20 | 0.55 |
| ▸ | PTK6 | Q13882 | 1/20 | 0.49 |
| ▸ | EGFR | P00533 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | PKM | P14618 | 2/20 | 0.46 |
| ▸ | CASP1 | P29466 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30342922 | 1.00 | ALDH1A1 (0.70) | ALDH1A1MAPTKDM4EMEN1KMT2A | |
| SCHEMBL31502235 | 0.87 | MAPT (0.53) | ALDH1A1MAPTKDM4EMEN1KMT2A | |
| SCHEMBL30342705 | 0.84 | ALDH1A1 (0.60) | ALDH1A1MAPTKDM4EMEN1KMT2A | |
| SCHEMBL12584903 | 0.79 | SMN1; SMN2 (0.72) | ALDH1A1MAPTKDM4EMEN1KMT2A | |
| SCHEMBL14103565 | 0.78 | SMN1; SMN2 (0.77) | ALDH1A1MAPTKDM4EMEN1KMT2A | |
| SCHEMBL12416695 | 0.77 | MAOB (0.70) | ALDH1A1MAPTKDM4EMEN1KMT2A | |
| SCHEMBL15600616 | 0.77 | SMN1; SMN2 (0.62) | ALDH1A1MAPTKDM4EMEN1KMT2A | |
| SCHEMBL30342828 | 0.77 | ALDH1A1 (0.44) | ALDH1A1MAPTKDM4EMEN1KMT2A | |
| SCHEMBL31502238 | 0.76 | MAPT (0.47) | ALDH1A1MAPTKDM4EMEN1KMT2A | |
| SCHEMBL30342710 | 0.76 | MEN1 (0.41) | ALDH1A1MAPTKDM4EMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250129015-A1 | HALOGENATED BENZYLIDINE DERIVATIVES | Renovel Innovations, Inc. (US) | 2025-04-24 | — | — | US | claimed |
| US-20250129015-A1 | HALOGENATED BENZYLIDINE DERIVATIVES | Renovel Innovations, Inc. (US) | 2025-04-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250129015-A1 | HALOGENATED BENZYLIDINE DERIVATIVES | BRD2, MPO, BRD9 | ALDH1A1 1995/4885MAPT 4063/4885KDM4E 1650/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.